Crestline Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Crestline Management’s Portfolio REGN Stock Details REGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$1.99M	Buy
2024 Q3	$816K	Buy
2019 Q4	–	Sell
2019 Q3	$7.91M	Buy